Celator Pharma Cmn (CPXX)
30.24 unch (unch) 07/12/16 [NASDAQ]
N/A x N/A N/A x N/A
Realtime by (Cboe BZX)
N/A x N/A N/A x N/A
Realtime - - (-) -
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -19,315 | -16,903 | -20,844 | -10,909 | -14,160 |
| Depreciation Amortization | 198 | 196 | 198 | 412 | 442 |
| Accounts receivable | -55 | 1,393 | 587 | -783 | -791 |
| Accounts payable and accrued liabilities | 65 | -462 | 492 | 198 | -729 |
| Other Working Capital | 1,392 | 608 | -26 | 1,249 | -1,639 |
| Other Operating Activity | 2,224 | 757 | 7,134 | 4,864 | 2,276 |
| Operating Cash Flow | $-15,490 | $-14,412 | $-12,460 | $-4,968 | $-14,600 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -55 | -65 | -41 | 26 | -93 |
| Investing Cash Flow | $-55 | $-65 | $-41 | $26 | $-93 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 5,000 | 9,827 | N/A | 5,423 | 2,577 |
| Debt Repayment | -427 | N/A | -3,000 | N/A | -49 |
| Common Stock Issued | 2,080 | 14,930 | 32,521 | 6,763 | 0 |
| Other Financing Activity | -237 | -1,438 | -3,080 | -837 | 4,993 |
| Financing Cash Flow | $6,415 | $23,319 | $26,441 | $11,349 | $7,520 |
| Exchange Rate Effect | -30 | -18 | 1 | 14 | 1 |
| Beginning Cash Position | 32,414 | 23,590 | 9,648 | 3,227 | 10,399 |
| End Cash Position | 23,253 | 32,414 | 23,590 | 9,648 | 3,227 |
| Net Cash Flow | $-9,160 | $8,824 | $13,942 | $6,421 | $-7,172 |
| Free Cash Flow | |||||
| Operating Cash Flow | -15,490 | -14,412 | -12,460 | -4,968 | -14,600 |
| Capital Expenditure | -55 | -65 | -93 | -36 | -380 |
| Free Cash Flow | -15,546 | -14,477 | -12,552 | -5,004 | -14,981 |